We provide funding so the brightest minds in pediatric cancer research can find the next big breakthrough.

What We Fund

What We Fund

To call pediatric cancer research “underfunded” is putting it lightly. Among the 12 different types of childhood cancers – yes, there are 12, with dozens of subtypes – the rarest of cancers go for decades without any progress.

Although we’ve made great strides in treating some childhood cancers in the past 50 years, current treatment protocols cause long-term, chronic health problems for survivors like organ damage, fertility issues, and even secondary cancers.

We seek solutions for the underdogs – the rare childhood cancers – so kids living with cancer don’t just survive, but thrive.

Since 2010, we have awarded $1,150,000 in Childhood Cancer Research Grants to sixteen institutions worldwide. Our researchers are searching for more effective treatment options, and for a better understanding of how childhood cancers behave.

Institutions Funded


Our Process

Our Grant Cycle

Past Recipients

Read about our 2015 Childhood Cancer Research Grant Awards!


*RENEWED!* Glypican-3 specific T-cells for the Adoptive Immunotherapy of Pediatric Liver Cancers
Andras Heczey M.D.
Texas Children’s Hospital/Baylor College of Medicine

Modification of Onconeuronal Antigens in the Neuroblastoma of Paraneoplastic OMS by Free RNA
Prof. Dr. Franz Blaes

Autoantigen Discovery in OMS – An Innovative Multidisciplinary Approach
Jessica Panzer, M.D., Ph.D., Miriam Rosenberg, Ph.D.
Children’s Hospital of Philadelphia/Weizmann Institute of Science

Critical Contributions of CRM1 to Pediatric Leukemogenesis
Jessica L. Heath, M.D.
University of Vermont

Development of a Material Hardship Intervention
Kira Bona, M.D., M.P.H.
Dana-Farber Cancer Institute


Glypican-3 specific T-cells for the Adoptive Immunotherapy of Pediatric Liver Cancers
Andras Heczey M.D.
Texas Children’s Hospital/Baylor College of Medicine

Identification and targeting of circulating Ewing’s sarcoma stem cells
Masanori Hayashi, M.D.
Johns Hopkins University

Identification of novel cdk4/6 effectors in T-cell acute lymphoblastic leukemia
John Carter, M.D., Ph.D.
Fred Hutchinson Cancer Research Center at Seattle Children’s Hospital

Detection of novel autoantibodies in children with OMS
Bethan Lang, M.D.
Oxford University

Targets of the Intrathecal B-Cell Response in Pediatric Opsoclonus Myoclonus Syndrome
Gregory Owens, Ph.D.
University of Colorado School of Medicine


*RENEWED!* miRNAs secreted by tumor associated macrophages and resistance in Neuroblastoma
Muller Fabbri M.D., Ph.D.
Saban Research Institute at Children’s Hospital Los Angeles and the University of Southern California

The role of the de-ubiquitinase USP44 in childhood germ cell tumorigenesis
Ying Zhang, Ph.D.
Mayo Clinic

Development of anti-tumor molecules targeting the Wilms tumor oncogene, LIN28B
Shilpa Pathak, Ph.D.
Roswell Park Cancer Institute


Role of the GAB2-SHP2 network in childhood neuroblastoma pathogenesis
Shizen Zhu, M.D., Ph.D.
Dana-Farber Cancer Institute

Phase I/II clinical trial evaluating NK cell immunotherapy in relapsed and refractory pediatric solid tumors
Monica Thakar, M.D.
Children’s Hospital of Wisconsin/Medical College of Wisconsin

Elucidating Epigenetic Mechanisms for Therapeutic Targeting in Aggressive Pediatric Cancers
Boris Wilson, Ph.D.
Dana-Farber Cancer Institute

Develop Small Molecule Yap Inhibitors to Treat Childhood Cancer
Chungling Yi, Ph.D.
Lombardi Cancer Center at Georgetown University


*RENEWED!* Phase I Dose Escalation Study of Sorafenib/Irinotecan Combination Therapy in Pediatric Relapsed Solid Tumors
Holly Meany, M.D.
Children’s National Medical Center

Alternative Lengthening of Telomeres in Neuroblastoma
Loretta Lau, M.D.
The Children’s Hospital at Westmead, Sydney, Australia

*RENEWED!* Identification of Clinical Biomarkers of Wilms Tumor Using High Accuracy Mass Spectroscopy Urine Proteome Profiling
Elizabeth Mullen, M.D.
Dana-Farber Cancer Institute

Apply for a Grant

The deadline for our 2015 Childhood Cancer Research Grants cycle has now passed. Applicants will be notified of their status on or before May 31, 2015.

The purpose of our research grants is to fund senior postdoctoral fellows/junior faculty (M.D. or Ph.D.) or to provide seed money to established investigators for innovative basic, translational, clinical, and epidemiological research directed to pediatric and adolescent cancer. Applications that focus on rare childhood cancers will be given preference. Applications from senior fellows and junior faculty investigators are particularly encouraged. To be added to the notification list for future research grant opportunities, please email with your name, title, institution, and research area of interest.

If you have questions about our research grant process or guidelines, please contact Grants Administrator Megan McMillan at

Featured Events

Featured Events

Pablove Across America 2015

WhenOctober 5, 2015

More Information Share Post

Sign-Up for the Pablove Foundation Mailing List